Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suchandrima Dutta

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cells|December 11, 2022
Advances in Cellular Reprogramming-Based Approaches for Heart Regenerative RepairXingyu He, Jialiang Liang, Christian Paul, et al.
Cells|January 28, 2026
Targeting Cardiac Fibroblast Plasticity for Antifibrotic and Regenerative Therapy in Heart FailureSuchandrima Dutta, Sophie Chen, Waqas Ahmad, et al.
Frontiers in Cell and Developmental Biology|May 8, 2026
<i>In vivo</i> CRISPR-mediated activation of cardiogenic genes to reprogram cardiac fibroblastsSuchandrima Dutta, Sophie Chen, Waqas Ahmad, et al.
Bioengineering (Basel, Switzerland)|September 27, 2025
In Vivo Targeted Reprogramming of Cardiac Fibroblasts for Heart Regeneration: Advances and Therapeutic PotentialWaqas Ahmad, Suchandrima Dutta, Xingyu He, et al.
Annals of Palliative Medicine|August 6, 2025
New progress and challenges of targeted therapies for breast cancerBoyu Wang, Xingyu He, Suchandrima Dutta, et al.
Canadian Journal of Physiology and Pharmacology|October 30, 2023
Direct cellular reprogramming techniques for cardiovascular regenerative therapeuticsXingyu He, Suchandrima Dutta, Jialiang Liang, et al.
Stem Cell Reviews and Reports|May 27, 2026
Oxygen-generating Microparticles Enhance Viability and Functionality of Human Pluripotent Stem Cell-derived Cardiomyocytes for Myocardial Infarction TherapyXingyu He, Suchandrima Dutta, Darshini Desai, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
Myocardial IGF2R is a critical mediator of inflammation and fibrosis after ischemia-reperfusion injuryZhichao Wu, Wei Huang, Xingyu He, et al.
Cells|January 9, 2026
Cell-Free Nucleic Acids in Cardiovascular Disease: From Biomarkers to Mechanistic Drivers and Therapeutic OpportunitiesHannah Morgan, Keara Little, Suchandrima Dutta, et al.
Annals of Palliative Medicine|September 11, 2025
A clinical practice review: management strategies and emerging approaches for anastomotic leakage following radical surgery for esophageal cancerSuchandrima Dutta, Sophie Chen, Xingyu He, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cells|December 11, 2022
Advances in Cellular Reprogramming-Based Approaches for Heart Regenerative RepairXingyu He, Jialiang Liang, Christian Paul, et al.
Cells|January 28, 2026
Targeting Cardiac Fibroblast Plasticity for Antifibrotic and Regenerative Therapy in Heart FailureSuchandrima Dutta, Sophie Chen, Waqas Ahmad, et al.
Frontiers in Cell and Developmental Biology|May 8, 2026
<i>In vivo</i> CRISPR-mediated activation of cardiogenic genes to reprogram cardiac fibroblastsSuchandrima Dutta, Sophie Chen, Waqas Ahmad, et al.
Bioengineering (Basel, Switzerland)|September 27, 2025
In Vivo Targeted Reprogramming of Cardiac Fibroblasts for Heart Regeneration: Advances and Therapeutic PotentialWaqas Ahmad, Suchandrima Dutta, Xingyu He, et al.
Annals of Palliative Medicine|August 6, 2025
New progress and challenges of targeted therapies for breast cancerBoyu Wang, Xingyu He, Suchandrima Dutta, et al.
Canadian Journal of Physiology and Pharmacology|October 30, 2023
Direct cellular reprogramming techniques for cardiovascular regenerative therapeuticsXingyu He, Suchandrima Dutta, Jialiang Liang, et al.
Stem Cell Reviews and Reports|May 27, 2026
Oxygen-generating Microparticles Enhance Viability and Functionality of Human Pluripotent Stem Cell-derived Cardiomyocytes for Myocardial Infarction TherapyXingyu He, Suchandrima Dutta, Darshini Desai, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
Myocardial IGF2R is a critical mediator of inflammation and fibrosis after ischemia-reperfusion injuryZhichao Wu, Wei Huang, Xingyu He, et al.
Cells|January 9, 2026
Cell-Free Nucleic Acids in Cardiovascular Disease: From Biomarkers to Mechanistic Drivers and Therapeutic OpportunitiesHannah Morgan, Keara Little, Suchandrima Dutta, et al.
Annals of Palliative Medicine|September 11, 2025
A clinical practice review: management strategies and emerging approaches for anastomotic leakage following radical surgery for esophageal cancerSuchandrima Dutta, Sophie Chen, Xingyu He, et al.
Pageof 2